The set of real numbers Ω K is chosen such that
holds for all p i ∈ R, i = 1, . . . , K.
Lee also showed that any subvector (p k 1 , . . . , p k m ), 1 ≤ k 1 < k 2 < . . . < k m ≤ K has a joint density of the form as in (1). This implies that elements of Ω K that satisfy the condition in (2) should also satisfy 1 + R Ω k m (p k 1 , . . . , p k m ) ≥ 0.
Consider a trivariate case, let the mixing function φ(p k ) = p k − µ k , k = 1, 2, 3 where p k ∈ [0, 1] and µ k is the expected value of p k then 1 + ω 12 (p 1 − µ 1 )(p 2 − µ 2 ) + ω 13 (p 1 − µ 1 )(p 3 − µ 3 ) + ω 23 (p 2 − µ 2 )(p 3 − µ 3 ) + ω 123 (p 1 − µ 1 )(p 2 − µ 2 )(p 3 − µ 3 ) ≥ 0.
To find the lower and upper bounds of each element of Ω 3 such that the condition is satisfied, we could substitute (p 1 , p 2 , p 3 ) with extreme points (0, 0, 0), (0, 0, 1), (0, 1, 0), (0, 1, 1), (1, 0, 0), (1, 0, 1), (1, 1, 0) and (1, 1, 1) to equation (3):
(0, 1, 1) :
(1, 0, 1) :
(1, 1, 0) :
(0, 0, 1) :
(0, 1, 0) :
(1, 0, 0) :
(1, 1, 1) :
From equations (4) and (8)
Similarly, from the following equations, the lower and upper bounds for the pairwise mixing parameters are (7) and (11) :
(4) and (9) :
(6) and (11) :
(4) and (10) :
(5) and (11) :
(5) and (9) : (6) and (10) :
(5) and (8) : (7) and (10) :
(6) and (8) :
(7) and (9) :
Henceforth, the lower and upper bounds for ω ij , i, j = 1, 2, 3 and i = j,
which is the case in the bivariate Sarmanov density.
From equations (4) to (11) the lower and upper bounds for ω 123 are
When a 1 = a 2 = a 3 = a and
Web Appendix B: Operating Characteristics of the Development Plan
Web Table 1 shows the operating characteristics of the development plan for bivariate Sarmanov beta density when the marginal prior densities of the first and second treatments are not identical.
Web Table 1 Number of optimal terminal actions taken after sampling 1000 times from a Bernoulli distribution with p = 0.52 for various prior distributions, Beta(a, b), and mixing parameter, ω (equivalently, correlation, ρ). Available terminal actions based on accumulated data at treatment 1 were to start a new phase II study (action T), move to a phase III study (action P) or abandon the development programme (action A); only the latter two options were available at treatment 2. The proportion of times action P or A was taken at treatment 2 is in brackets. The median and range of the number of study participants needed to make a terminal action are shown for both treatments. 
Web Appendix C: Decision Rules for the Second Phase II Trial
Web Figures 1-3 show the decision schemes of the second treatment for Beta(3, 2), Beta(1, 1) and Beta(2, 3), respectively, assuming that action T was the optimal action after observing responses from n 1+ = 10 patients from the first trial. Web Figure 3 : Decision rules for optimal actions for the second phase II trial after observing n 1+ = 10 patients from treatment 1 and p 1 , p 2 ∼ Beta(2, 3) based on (a) independent treatment effects, ρ = 0 (equivalently, ω = 0) and (b)-(d) correlated treatment effects, ρ = 0.33 (equivalently, ω = 4). In the correlated case, assuming (b) s 1+ = 1, (c) s 1+ = 2 and (d) s 1+ = 3 successes were observed in treatment 1.
